).
In numerous studies it has been demonstrated that enamel matrix derivatives (EMD) modulate the behavior of cells in stimulating proliferation, inducing production of transforming growth factor ß as well as interleukin-6 and differentiation of immature cells in vitro (Foster et al. 2006 , Giannobile & Somerman 2003 , Hakki et al. 2001 , Lyngstadaas et al. 2001 , Okubo et al. 2003 , Sato et al. 2008 , Schwartz et al. 2000 , Swanson et al. 2006 , Tokiyasu et al. 2000 , Van der Pauw et al.
2000)
EMD favor the formation of a new attachment apparatus In vivo, characterized by the presence of acellular and cellular cementum with inserting collagen fibres and new alveolar bone (Hammarstrom 1997 , Hammarstrom et al. 1997 , Heijl et al. 1997 , Jepsen et al. 2004 , Meyle et al. 2004 , Sculean et al. 2000 , Sculean et al. 2001 In several controlled clinical trials treatment of intrabony defects with EMD resulted in significantly more attachment gain and bone fill than open flap debridement (Esposito et al. 2005 , Froum et al. 2001a , Froum et al. 2001b , Sanz et al. 2004 , Tonetti et al. 2004a , Tonetti et al. 2004b , Tonetti et al. 2002 . EMD was also successfully used in class II furcation defects.. Compared with guided tissue regeneration EMD treatment resulted in reduced postoperative swelling and pain (Jepsen et al. 2004 , Meyle et al. 2004 , Hoffmann et al. 2006 .
In wider defects the viscous nature of EMD doesn't prevent the collapse of the soft tissue flap into the defect. Therefore EMD have been combined with different space-F o r P e e r R e v i e w 5 maintaining products (e.g. membranes or bone substitutes) in order to enhance the space for periodontal regeneration (Donos et al. 2006 , Dori et al. 2005 , Pietruska 2001 , Rosen & Reynolds 2002 , Sculean et al. 2002 , Sculean et al. 2003 , Sculean et al. 2008b , Sculean et al. 2001 , Trombelli & Farina 2008 , Trombelli et al. 2002 , Zucchelli et al. 2003 . Controlled clinical studies indicate that a combination of EMD and bovine derived xenograft may enhance gain of clinical attachment (Lekovic et al. 2001 , Zucchelli et al. 2002 . It is still questionable, if graft materials are substituted by newly formed bone (Sculean et al. 2008c) . Recently the combination of EMD with autogenous bone indicated that , this combined approach led to less recession as compared with EMD alone (Guida et al. 2007 ). Similar results were reported when EMD was compared with a bovine derived xenograft (Mellonig 2006 , VelasquezPlata et al. 2002 . In a recent review it was concluded that the additional use of a graft (autogenous bone, DFDBA, BPBM, bioactive glass) seems to enhance the clinical outcome of EMD over EMD alone (Trombelli & Farina 2008) .
Biphasic calcium phosphates have been used as bone substitutes in orthopedic, cranio/maxillofacial, oral and periodontal surgery and have been shown to be biocompatible, safe, and effective scaffolds for the formation of new bone (Daculsi et al. 1999 , Nery et al. 1992 , Piattelli et al. 1996 . Preclinical evidence suggests that a biphasic calcium phosphate (BCP) with >99% cristallinity, consisting of 60% hydroxyapatite (HA) and 40% ß-tri-calcium-phosphate (TCP) in particulate preparation may accelerate new bone formation (Nery et al. 1992) .
In this study we compared the clinical and radiographic outcomes of EMD in combination with synthetic bone substitute or EMD alone in the treatment of wide intrabony defects after 12 months. The amount of defect fill 6 and 12 months following two different regenerative treatments of 1-and 2-wall intrabony periodontal defects was studied in a randomized, prospective, multi-centre controlled clinical trial. Details of the study protocol, statistical analysis and clinical results after 6 months have been reported previously (Jepsen et al. 2008) .
Materials and Methods

F
Briefly an access flap was prepared with papilla preservation (Cortellini et al. 1995 (Cortellini et al. , 1999 . After debridement, removal of granulation tissue and remaining subgingival calculus, enamel matrix derivatives were applied (Straumann® Emdogain, Straumann, Basel, Switzerland) (EMD). Subsequently in the test group the defects were filled with a synthetic bone graft (Straumann® BoneCeramic, Straumann, Basel, Switzerland) (SBG), which had been mixed with EMD. In the controls EMD was used alone. The flap was repositioned and closed with monofilament synthetic non -resorbable 5-0 and 6-0 suturing material (Ethicon Prolene, Ethicon Products, Norderstedt, Germany). All patients were controlled after 3, 6, 9 and 12 months . No subgingival instrumentation was performed at the surgical site.
Five centers participated involving a total of five operators and five masked examiners connected with and supervised by a central monitoring facility at the Institut Straumann AG, Basel, Switzerland.
Subject population
For a detailed description see (Jepsen et al. 2008 75 patients gave informed consent and were enrolled. A randomization list was generated by an independent statistician based on 1 surgical site per patient for a total of 75 surgical sites. To conceal assignment the investigator was instructed to assign a previously supplied sealed envelope containing the treatment assignment to the specific patient. The original randomization allocation could not be used for a replacement patient.
Clinical measurements
Clinical outcomes were evaluated after 6 and 12 months. During surgery width and depth of the intrabony defect was assessed with a manual probe (PCP-UNC 15, Hu-Friedy, Leimen, Germany). The following assessments were performed: 1) bone level (distance from stent to bottom of the defect); 2) defect depth (distance bone crest to bottom of bone defect); 3) defect width (horizontally from the bone crest at the experimental site in a direction towards the center of the tooth) and; 4) determination of the defect type (1-wall, 2-wall, combined 1-and 2-wall or circumferential). Any adverse effect or post-surgical complications were recorded using a questionnaire. and exposure time were chosen according to tooth type. The radiographs were obtained immediately prior to and 12 months after surgery using F-speed films (Insight, Kodac, Rochester, CT, USA). All radiographs were sorted in random order and numbered from 1 to 150 by the investigator of the radiographic analysis (P.E.), who also determined the coronal landmark (CEJ or restoration margin: RM). All radiographs where the anatomical landmarks or the defects could not be properly identified were excluded.
Radiographs were digitized using a computer program (SIDEXIS nextGeneration Analysis started with number 1 in the order given by one examiner (C.M.) who was blinded to the clinical results and to the time point the particular radiographs had been taken (baseline, 12 months) (Eickholz et al. 2004a , Eickholz et al. 2004b , Klein et al. 2001 . Each radiograph was identified by its number.
For evaluation the analysing tool of the program SIDEXIS was used. The images were magnified once using the "zoom" function. Then the distances CEJ/RM to alveolar crest (AC), CEJ/RM to DB, the depth of the intrabony component (INTRA), and the angle between root surface and lateral bone wall were measured ( Figure 1 and 2). If radiographs were too dark or had too low contrast to identify landmarks the examiner was allowed to adjust brightness and contrast. If basic image enhancement functions (brightness, contrast) were insufficient to make land marks visible the examiner was instructed to exclude these images from analysis.
Definition of radiographic landmarks
The radiographic landmarks were defined as follows: if the CEJ was destroyed by restorative treatment it was replaced by the margin of the restoration (RM) (Fig. 2a ). (Fig. 1) . If no periodontal ligament space could be identified, the point where the projection of the AC crossed the root surface was used (Benn 1992).
If both structures could be identified, the point defined by the periodontal ligament was used as BD and the crossing of the silhouette of the alveolar crest with the root surface was defined as AC. If several bony contours could be identified, the most apical one that crossed the root was defined as the BD and the most coronal one as AC (Eickholz et al. 1996) . For all intrabony defects the distances CEJ/RM to AC and CEJ/RM to BD were measured using the measurement tool (Fig. 2a, b) , also a first auxiliary line (AUX1) was drawn to represent the tooth axis (Fig. 2c) . Then using the angle function a 90° angle was drawn with AUX1 as one leg. This angle was moved along AUX1 until the other leg (AUX2) ran through the most coronal margin of the intrabony defect (M3) (Fig. 1a, 2c ). The depth of the intrabony defect (INTRA) was measured as distance between BD and the crossing of the silhouette of the root surface and AUX 2 (Fig. 2c) . Using the function "angle" the width of the intrabony defect was assessed as an angle. One leg of this angle ran through BD and M3, the other through BD and CEJ/RM (Klein et al. 2001 , Eickholz et al. 2004a ,b, Pretzl et al. 2009 ) (Fig. 2d ).
To assess intraindividual reproducibility measurements were repeated in 20
radiographs (approximately each 10th radiograph) after all radiographs had been evaluated once.
Both (investigator and examiner of the radiographic analysis) were blinded for the clinical parameters and treatment assignment as well as the time point the radiographs had been taken (baseline, 12 months). Using 20 radiographs of intrabony defects unrelated to this study the examiner was calibrated prior to evaluation by the investigator of the radiographic analysis in finding the anatomical 
Data management and statistical analysis of clinical data
Statistical management of data for the 6 months results has been reported previously (Jepsen et al. 2008 ). Statistical analysis after 12 months was mostly of descriptive nature. Based on the study protocol testing the hypothesis of non-inferiority of EMD/SBG compared with EMD had been performed after 6 months. Two patientsone in each group -dropped out prematurely. As no data for the efficacy variable was available after baseline (surgery), these two could not be considered for analysis according to the intention-to-treat-principle. Hence, the data analysis had to be limited to 73 subjects. For data processing and statistical evaluation, appropriate validated software was used (SPSS software package, version 13, SPSS, Chicago, IL, USA).
The primary outcome variable was the change in defect fill recorded by bone sounding 6 months after surgery. Bone sounding values at baseline and after 12 months were compared by t-test in both treatment groups. Mean changes and 95% confidence intervals were computed.
Secondary variables included RAL, PPD 12 months after surgery, which were compared descriptively between the treatment groups. Secondary variables were also the differences between the distances from the cemento enamel junction (CEJ)
to the most apical extension of the bony defect (BD) on radiographs obtained prior to and 12 months after surgery. All radiographic measurements were entered in a (Cohen & Ralls 1988) . For the distances CEJ/RM-BD, CEJ/RM-AC, and INTRA the interindividual reproducibility was assessed as amount of differences > 1.0 mm.
The patient was looked upon as statistical unit. The outcome variable of the radiographic evaluation was the difference between the distance CEJ/RM to BD at baseline and 12 month after surgery (absolute defect fill). Baseline and 12 months results were compared using the Wilcoxon test. Between groups differences (EMD vs. EMD/SBG) were tested using the Mann Whitney U test. Factors influencing defect fill (change of distance CEJ/RM-BD from baseline to 12 months after therapy)
were identified using multiple linear regression analysis including the following independent variables: therapy (EMD vs. EMD/SBG), baseline INTRA, baseline defect angle. The full analysis was described in detail in a specific statistical analysis plan before unblinding data. The significance level was set at p < 0.05 . 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Clinical outcomes
Both treatment modalities led to significant improvements measured by bone sounding. The mean defect fill in the EMD/SBG group was 2.7 mm [95%CI (2.03 -3.26), p < 0.001, t-test), and 2.8 mm [95%CI (2.26 -3.36), p < 0.001, t-test) in the EMD group (Table 1) . Bone gain in the combined treatment group showed a higher variability as indicated by a higher standard deviation. A reduction of PPD was found after the combined treatment (2.8 ±2.1 mm; p < 0.001, t-test) as well as after EMD alone (2.9±1.8 mm; p < 0.001, t-test). In the test group a mean gain of attachment of 1.7±2.1 mm (p < 0.001, t-test) was observed and in the control group of 1.9±1.7 mm (p < 0.001, t-test). In the EMD/SBG treated group mean gingival recessions increased by 1.1±1.3 mm and in the control group (EMD) by 1.0±1.1 mm (Table 1) .
Both therapies resulted in significant reductions of PPD and gain of attachment.
Between groups no differences were found for any of the variables as well as for the changes of each variable. As compared with the 6-month data a slight (insignificant) increase in attachment gain (EMD: 1.8 to 1.9 mm and EMD/SBG 1.3 to 1.7 mm) and pocket reduction (EMD: 2.6 to 2.9 mm and EMD/SBG 1.9 to 2.8 mm) was observed.
Full mouth plaque scores ranged between 12.2% and 14.5% at all time points with no significant differences between groups (Table 2) . At baseline local plaque scores at 
Radiographic outcomes
During radiographic analysis 3 pairs of radiographs were excluded because of excentric projection and overlapping of crowns. One pair of radiographs was not evaluated, because the 12 months radiograph exhibited a bending mark within the defect and another pair could not be evaluated because the 12 months radiograph was lost. Finally a total of 136 radiographs (68 pairs) were analysed. Some minor differences in defect fill were observed depending upon the topography (Figure 3a, b) . In circumferential defects the variation was higher than in others without reaching statistical significance. Both treatment modalities resulted in significant defect fill. This led to a significant (p < 0.001) reduction of CEJ/RM-BD (EMD/SBG: 1.77±1.92 mm; EMD: 1.40±1.93 mm) and INTRA (EMD/SBG: 2.19±2.21 mm; EMD: 1.49±1.89 mm), which was also reflected in a significant (p < 0.01) increase of the defect angle (EMD/SBG: 9.0±14.4°; EMD: 6.7±13.0°). However, 
Discussion
Clinical results
The results of the present, randomized-controlled trial demonstrate favourable outcomes after 12 months.
Both treatment modalities resulted in statistically significant defect fill with significant reductions of the distance from apical to coronal radiological landmarks as well as the intraosseous depth of defect, which was also reflected in an increase of the defect angle.. No differences were found between treatment modalities.
The results of the present investigation are confirmed by several other studies and systematic reviews (Esposito et al. 2005 , Francetti et al. 2005 , Froum et al. 2001b , Pontoriero et al. 1999 , Sculean et al. 2008a , Tonetti et al. 2002 , Wachtel et al. 2003 .
In 2008 Sculean demonstrated that the treatment of intrabony defects with enamel matrix proteins may result in a reduction of pocket probing depth and gain of clinical attachment, which could be maintained over a period of 10 years. The present results confirm that after 12 months significant improvements in clincial parameters can be obtained in 1-and 2-wall intrabony defects after treatment with enamel matrix proteins and a bone replacement graft. Since hard tissue fill is the only component of regenerated peridontium which can be assessed clinically, bone sounding was performed and served as primary outcome variable (Machtei 1997 Osseous regeneration after treatment with EMD in combination with a biphasic calcium phosphate in humans requires more than 9 months as outlined in a human histological analysis by (Sculean et al. 2008c ). Lekovic (2000) reported about significant improvements if EMD were combined with bovine porous bone mineral. The improvements were observed on the buccal and lingual sites despite the fact that interproximal defects were treated (Lekovic et al. 2000) . In 2003 Zucchelli et al. reported about significantly greater attachment gain and bone gain with a combination of EMD and bone mineral (Zucchelli et al. 2003) . It is obvious that the defect characteristics were different from our study. The authors reported about a mean intrabony defect depth of 6.8 mm whereas in our study this was 5.9 and 5.6 mm respectively. In other trials only slight differences between the 2 treatment groups (EMD versus EMD+SBG) were observed (Bokan et al. 2006) A systematic review has shown that clinical parameters are improved when intrabony defects are treated with bone fillers (Reynolds et al. 2003 ). Similar results were described by Yilmaz et al. (2010) , who compared EMD combined with/without autogenous bone in two to three wall intrabony defects (Yilmaz et al. 2010) . They reported about a small but significantly higher gain of relative attachment level. In general it appears that the combination of EMD with bone grafts or autogenous bone seems to be more favourable than a combination of EMD with barrier membranes if intrabony lesions are treated (Tu et al. 2010 ).
According to our data in wide 1-wall and 2-wall defects the effect of EMD can not be improved by adding a SBG. After 12 months there was no substantial improvement as compared with 6 month data (Jepsen et al. 2008 ).
Radiographic results
For calibration the radiographic examiner achieved better reproducibility than during evaluation of the investigational radiographs. The radiographs chosen for training 1.49±1.89 mm) 12 months after therapy corresponds well to results reported 12 months after GTR therapy of intrabony defects with non-resorbable barriers (CEJ/RM-BD: ePTFE: 1.9 mm [Eickholz et al. 1998 ]) as wellas with resorbable membranes (CEJ/RM-BD: Polyglactin 910: 1.4 mm [Eickholz et al. 1998 ].
Eight and 16 months after use of EMD in 1-and 2-walled intrabony defects radiographic bone gain of 0.9 mm and 2.2 mm was reported (Heijl et al. 1997) . Better radiographic defect fill was observed 12 months after therapy of 3-wall intrabony defects with non-resorbable barriers or EMD (ePTFE: 2.9 mm, EMD: 2. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 F o r P e e r R e v i e w 18 obtained with individual stent film holders as in this study (Eickholz et al. 1998 , Pretzl et al. 2009 , Crea et al. 2009 ).
Not only after 6 but also after 12 months the data support the effectiveness and safety of regenerative procedures based on EMD application..The differences in attachment gain between our study and previous investigations can easily be explained by defect topography: in our study wide (≥ 2 mm) non contained (1-and 2-walled) intrabony defects were treated.
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